Recent report from Syft highlights hospital supply chain challenges at the point-of-use and key areas that need improvement.
Nurses face significant supply chain management problems that impact efficiency, patient safety, and hospital margins, according to a recent survey from Syft, a leading national provider of healthcare inventory control and end-to-end supply chain cost management software and services.
The survey is conducted of 100 hospital frontline nurses and nurse leaders that sought to understand their perspectives of hospital supply chains, according to the release from Syft.
Conducted in February 2021, key findings include:
Many nurses said supply chain challenges impact patient safety.
Supply chain problems take a significant toll on nurse stress and burnout.
Nurses say supply chain problems result in excess waste and lower margins.
"Hospitals are taking steps to improve their supply chains after seeing vulnerabilities exposed by COVID-19, but these findings show that they won't be successful until they start factoring in the nurse experience," said Todd Plesko, CEO of Syft. "Nurses are experiencing pervasive and troubling challenges related to efficiency, patient safety, waste, and mental health due to supply chains not recognizing their needs. Creating a more nurse-centric supply chain is critical to every hospital's success."
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
March 18th 2024Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
Read More
FDA Updates for Week of March 11: First CAR-T for CLL/SLL and First NASH Treatment
March 16th 2024The FDA this week approved a few firsts: the first treatment for NASH and the first CAR-T cell therapy for CLL/SLL. Other approvals include Tevimbra for esophageal cancer; Livmarli for second liver disease indication; and Praluent for children with genetic form of high cholesterol. The FDA also issued a CRL for monthly MS drug. Additionally, Celltrion submitted an application for an interchangeable Xolair biosimilar.
Read More
A Deep Dive into Predictive and Generative AI with Lynn Carroll of HSBlox
January 3rd 2024In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.
Listen
Transforming the management of genetic testing
March 15th 2024This e-book will explain where the current genetic test management system is inadequate and how a new approach designed specifically for genetic testing will perform better and provide more meaningful and actionable results.
Read More